These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20696868)

  • 21. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells.
    Zemke AC; Shiva S; Burns JL; Moskowitz SM; Pilewski JM; Gladwin MT; Bomberger JM
    Free Radic Biol Med; 2014 Dec; 77():307-16. PubMed ID: 25229185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa biofilms.
    Zemke AC; Gladwin MT; Bomberger JM
    Antimicrob Agents Chemother; 2015; 59(6):3329-34. PubMed ID: 25801569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
    Wang Z; De Soir S; Glorieux A; Merabishvili M; Knoop C; De Vos D; Pirnay JP; Van Bambeke F
    Int J Antimicrob Agents; 2024 Sep; 64(3):107276. PubMed ID: 39009289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
    Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
    Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
    McGhee P; Clark C; Credito K; Beachel L; Pankuch GA; Appelbaum PC; Kosowska-Shick K
    Antimicrob Agents Chemother; 2011 May; 55(5):2417-9. PubMed ID: 21343445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa.
    Al-Bakri AG; Gilbert P; Allison DG
    J Basic Microbiol; 2005; 45(5):392-6. PubMed ID: 16187262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.
    Saiman L; Tabibi S; Starner TD; San Gabriel P; Winokur PL; Jia HP; McCray PB; Tack BF
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2838-44. PubMed ID: 11557478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
    Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Burkholderia cepacia and other pathogens of importance in cystic fibrosis to u.v. light.
    Cairns G; Kerr KG; Beggs CB; Sleigh PA; Mooney L; Keig P; Donnelly JK
    Lett Appl Microbiol; 2001 Mar; 32(3):135-8. PubMed ID: 11264740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
    Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
    Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.
    Mathee K; Ciofu O; Sternberg C; Lindum PW; Campbell JIA; Jensen P; Johnsen AH; Givskov M; Ohman DE; Søren M; Høiby N; Kharazmi A
    Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1349-1357. PubMed ID: 10411261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.